OLUKOTUN ADEOYE Y sold ARWR
January 23, 2025 · Form 4 insider transaction
OLUKOTUN ADEOYE Y sold 959 shares of Arrowhead Pharmaceuticals, Inc. at $21.00 per share, a transaction worth $20.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
959
Price
$21.00
Total value
$20.1K
InsiderOLUKOTUN ADEOYE Y
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 23, 2025
Filing dateJanuary 27, 2025
Shares owned after35,781
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.; Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.